COO - The Cooper Companies, Inc.
After hours:
| Previous close | 374.19 |
| Open | 360.13 |
| Bid | 356.59 x 800 |
| Ask | 362.80 x 800 |
| Day's range | 356.05 - 364.50 |
| 52-week range | 244.22 - 395.20 |
| Volume | |
| Avg. volume | 300,180 |
| Market cap | 17.629B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 49.51 |
| EPS (TTM) | 7.20 |
| Earnings date | 29 Aug 2023 - 04 Sept 2023 |
| Forward dividend & yield | 0.06 (0.02%) |
| Ex-dividend date | 20 Jan 2023 |
| 1y target est | 397.17 |
ZacksCooper Companies (COO) Q2 Earnings and Revenues Beat Estimates
Cooper Companies' (COO) second-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.
ZacksThe Cooper Companies (COO) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ZacksThe Cooper Companies (COO) Q2 Earnings and Revenues Surpass Estimates
The Cooper Companies (COO) delivered earnings and revenue surprises of 2.33% and 1.75%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireCooperCompanies Announces Second Quarter 2023 Results
SAN RAMON, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2023. Revenue increased 6% year-over-year to $877.4 million. CooperVision (CVI) revenue up 6% to $589.3 million, and CooperSurgical (CSI) revenue up 4% to $288.1 million.GAAP diluted earnings per share (EPS) of $0.80, down $1.75 or 69% from last year's second quarter.Non-GAAP diluted EPS of $3.08, down $0.16 or 5% from last year's second
ZacksIs a Beat Likely for Cooper Companies (COO) in Q2 Earnings?
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
ZacksWhat Makes The Cooper Companies (COO) a New Buy Stock
The Cooper Companies (COO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and The Cooper Companies (COO) have performed compared to their sector so far this year.
- GlobeNewswire
CooperCompanies to Present at the Jefferies Healthcare Conference
SAN RAMON, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 8, 2023. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled to begin at 2:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be available on the sa
ZacksXRAY vs. COO: Which Stock Is the Better Value Option?
XRAY vs. COO: Which Stock Is the Better Value Option?
ZacksWhy You Should Buy The Cooper Companies (COO) Stock Now
The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.
ZacksAnaptysBio, Inc. (ANAB) Reports Q1 Loss, Misses Revenue Estimates
AnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of -51.92% and 65.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
CooperCompanies Publishes 2022 Environmental, Social, and Governance Report, Shares Progress on Creating Value for Stakeholders
SAN RAMON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today released its 2022 Environmental, Social, and Governance (ESG) Report. It highlights the company's progress on social and environmental issues most important to its businesses and stakeholders, including employees, shareholders, customers, and global communities. In 2022, CooperCompanies manufactured a record number of products while reducing greenhouse gas (GHG) emissions by more than 7%. A big contributor to t
ZacksHenry Schein (HSIC) Q1 Earnings and Revenues Miss Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of -2.42% and 1.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksXRAY vs. COO: Which Stock Should Value Investors Buy Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
ZacksCardinal Health (CAH) Tops Q3 Earnings and Revenue Estimates
Cardinal (CAH) delivered earnings and revenue surprises of 17.57% and 1.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
CooperCompanies Announces Release Date for Second Quarter 2023
SAN RAMON, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report second quarter 2023 financial results on Thursday, June 1, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7116518. A simultaneous audio webcast can be accessed on CooperCompanies’ investor relations websi
ZacksZacks Industry Outlook Highlights West Pharmaceutical Services, The Cooper Companies and Henry Schein
West Pharmaceutical Services, The Cooper Companies and Henry Schein have been highlighted in this Industry Outlook article.
- Zacks
3 Dental Supplies Stocks to Buy as Industry Prospects Recover
Here, we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, COO and HSIC.
ZacksCatalent (CTLT) Declines on Profit Warnings and CFO Exit
Catalent (CTLT) issues a profit warning for third-quarter fiscal 2023 amid supply chain disruptions and operational challenges. It also announces the departure of its CFO.
Simply Wall St.Cooper Companies (NYSE:COO) Might Be Having Difficulty Using Its Capital Effectively
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
ZacksHere's Why You Should Retain Surmodics (SRDX) Stock for Now
Investors continue to feel optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.
ZacksXRAY or COO: Which Is the Better Value Stock Right Now?
XRAY vs. COO: Which Stock Is the Better Value Option?
- Zacks
Reasons to Add The Cooper Companies (COO) to Your Portfolio
The Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to drive the top line further.
- Simply Wall St.
Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Cooper Companies fair value estimate is US$329 Current share...
- Zacks
Here's Why You Should Retain Patterson Companies (PDCO) Stock
Investors are optimistic about Patterson Companies' (PDCO) strong product line.